Clinical trial
Infliximab to Treat Children With Juvenile Rheumatoid Arthritis
NCT00029042 · National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), NIH · Terminated
Key facts
| NCT number | NCT00029042 |
|---|---|
| Title | Infliximab to Treat Children With Juvenile Rheumatoid Arthritis |
| Official title | A Randomized Double Blind Controlled Intra-Patient Dose Escalation Phase II Trial of Infliximab in Pediatric Patients With Refractory Juvenile Rheumatoid Arthritis |
| Lead sponsor | National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), NIH |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Juvenile Rheumatoid Arthritis |
| Intervention type | Drug |
| Interventions | Infliximab |
| Enrollment | 48 |
| Start date | Jan 1, 2002 |
| Completion | Oct 1, 2005 |
| First posted | Jan 7, 2002 |
| Last update posted | Aug 27, 2008 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: